Cargando…
Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors
Germline inactivation of the von Hippel-Lindau (VHL) tumor suppressor predisposes patients to develop different highly vascularized cancers. pVHL targets the hypoxia-inducible transcription factor (HIF-1α) for degradation, modulating the activation of various genes involved in hypoxia response. Hypo...
Autores principales: | Minervini, Giovanni, Lopreiato, Raffaele, Bortolotto, Raissa, Falconieri, Antonella, Sartori, Geppo, Tosatto, Silvio C. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397843/ https://www.ncbi.nlm.nih.gov/pubmed/28425505 http://dx.doi.org/10.1038/srep46562 |
Ejemplares similares
-
The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel–Lindau tumor suppressor
por: Falconieri, Antonella, et al.
Publicado: (2020) -
Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening
por: Falconieri, Antonella, et al.
Publicado: (2022) -
The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform
por: Chesnel, F, et al.
Publicado: (2015) -
Design and Analysis of a Petri Net Model of the Von Hippel-Lindau (VHL) Tumor Suppressor Interaction Network
por: Minervini, Giovanni, et al.
Publicado: (2014) -
Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein
por: Minervini, Giovanni, et al.
Publicado: (2015)